1	When	_	WRB	_	_	4	TMP	_	_
2	the	_	DT	_	_	3	NMOD	_	_
3	economy	_	NN	_	_	4	SBJ	_	_
4	stumbled	_	VBD	_	_	11	TMP	_	_
5	in	_	IN	_	_	4	TMP	_	_
6	the	_	DT	_	_	7	NMOD	_	_
7	mid-1970s	_	CD	_	_	5	PMOD	_	_
8	,	_	,	_	_	11	P	_	_
9	Akzo	_	NNP	_	_	10	NAME	_	_
10	NV	_	NNP	_	_	11	SBJ	_	_
11	fell	_	VBD	_	_	0	ROOT	_	_
12	out	_	IN	_	_	11	ADV	_	_
13	of	_	IN	_	_	12	PMOD	_	_
14	bed	_	NN	_	_	13	PMOD	_	_
15	.	_	.	_	_	11	P	_	_

1	Towering	_	VBG	_	_	2	NMOD	_	_
2	overcapacity	_	NN	_	_	21	SBJ	_	_
3	in	_	IN	_	_	2	LOC	_	_
4	the	_	DT	_	_	7	NMOD	_	_
5	synthetic	_	JJ	_	_	7	NMOD	_	_
6	fiber	_	NN	_	_	7	NMOD	_	_
7	business	_	NN	_	_	3	PMOD	_	_
8	,	_	,	_	_	7	P	_	_
9	which	_	WDT	_	_	10	SBJ	_	_
10	accounted	_	VBD	_	_	7	NMOD	_	_
11	for	_	IN	_	_	10	ADV	_	_
12	half	_	NN	_	_	11	PMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	the	_	DT	_	_	17	NMOD	_	_
15	Dutch	_	JJ	_	_	17	NMOD	_	_
16	chemical	_	NN	_	_	17	NMOD	_	_
17	company	_	NN	_	_	19	NMOD	_	_
18	's	_	POS	_	_	17	SUFFIX	_	_
19	sales	_	NNS	_	_	13	PMOD	_	_
20	,	_	,	_	_	2	P	_	_
21	led	_	VBD	_	_	0	ROOT	_	_
22	to	_	TO	_	_	21	ADV	_	_
23	huge	_	JJ	_	_	24	NMOD	_	_
24	losses	_	NNS	_	_	22	PMOD	_	_
25	and	_	CC	_	_	21	COORD	_	_
26	left	_	VBD	_	_	25	CONJ	_	_
27	Akzo	_	NNP	_	_	29	NMOD	_	_
28	's	_	POS	_	_	27	SUFFIX	_	_
29	survival	_	NN	_	_	26	OBJ	_	_
30	in	_	IN	_	_	26	ADV	_	_
31	doubt	_	NN	_	_	30	PMOD	_	_
32	.	_	.	_	_	21	P	_	_

1	It	_	PRP	_	_	2	SBJ	_	_
2	was	_	VBD	_	_	0	ROOT	_	_
3	n't	_	RB	_	_	2	ADV	_	_
4	until	_	IN	_	_	2	PRD	_	_
5	the	_	DT	_	_	7	NMOD	_	_
6	early	_	JJ	_	_	7	NMOD	_	_
7	1980s	_	CD	_	_	4	PMOD	_	_
8	that	_	IN	_	_	10	TMP	_	_
9	Akzo	_	NNP	_	_	10	SBJ	_	_
10	nursed	_	VBD	_	_	4	PMOD	_	_
11	itself	_	PRP	_	_	10	OBJ	_	_
12	back	_	RB	_	_	10	ADV	_	_
13	to	_	TO	_	_	12	AMOD	_	_
14	health	_	NN	_	_	13	PMOD	_	_
15	.	_	.	_	_	2	P	_	_

1	Now	_	RB	_	_	14	TMP	_	_
2	,	_	,	_	_	14	P	_	_
3	as	_	IN	_	_	14	TMP	_	_
4	a	_	DT	_	_	6	NMOD	_	_
5	new	_	JJ	_	_	6	NMOD	_	_
6	downturn	_	NN	_	_	11	SBJ	_	_
7	in	_	IN	_	_	6	LOC	_	_
8	the	_	DT	_	_	10	NMOD	_	_
9	chemical	_	NN	_	_	10	NMOD	_	_
10	industry	_	NN	_	_	7	PMOD	_	_
11	looms	_	VBZ	_	_	3	SUB	_	_
12	,	_	,	_	_	14	P	_	_
13	Akzo	_	NNP	_	_	14	SBJ	_	_
14	says	_	VBZ	_	_	0	ROOT	_	_
15	it	_	PRP	_	_	16	SBJ	_	_
16	is	_	VBZ	_	_	14	OBJ	_	_
17	in	_	IN	_	_	16	PRD	_	_
18	far	_	RB	_	_	19	AMOD	_	_
19	better	_	JJR	_	_	20	NMOD	_	_
20	shape	_	NN	_	_	17	PMOD	_	_
21	to	_	TO	_	_	20	NMOD	_	_
22	cope	_	VB	_	_	21	IM	_	_
23	.	_	.	_	_	14	P	_	_

1	Investment	_	NN	_	_	2	NMOD	_	_
2	analysts	_	NNS	_	_	4	SBJ	_	_
3	generally	_	RB	_	_	4	ADV	_	_
4	agree	_	VBP	_	_	0	ROOT	_	_
5	.	_	.	_	_	4	P	_	_

1	Aside	_	RB	_	_	13	ADV	_	_
2	from	_	IN	_	_	1	AMOD	_	_
3	slashing	_	VBG	_	_	2	PMOD	_	_
4	costs	_	NNS	_	_	3	OBJ	_	_
5	and	_	CC	_	_	3	COORD	_	_
6	investing	_	VBG	_	_	5	CONJ	_	_
7	heavily	_	RB	_	_	6	MNR	_	_
8	in	_	IN	_	_	6	ADV	_	_
9	its	_	PRP$	_	_	10	NMOD	_	_
10	plants	_	NNS	_	_	8	PMOD	_	_
11	,	_	,	_	_	13	P	_	_
12	Akzo	_	NNP	_	_	13	SBJ	_	_
13	has	_	VBZ	_	_	0	ROOT	_	_
14	spent	_	VBN	_	_	13	VC	_	_
15	3.9	_	CD	_	_	16	DEP	_	_
16	billion	_	CD	_	_	17	NMOD	_	_
17	guilders	_	NNS	_	_	14	OBJ	_	_
18	(	_	(	_	_	19	P	_	_
19	$	_	$	_	_	17	PRN	_	_
20	1.88	_	CD	_	_	19	DEP	_	_
21	billion	_	CD	_	_	19	DEP	_	_
22	)	_	)	_	_	19	P	_	_
23	on	_	IN	_	_	14	ADV	_	_
24	acquisitions	_	NNS	_	_	23	PMOD	_	_
25	since	_	IN	_	_	14	TMP	_	_
26	1983	_	CD	_	_	25	PMOD	_	_
27	to	_	TO	_	_	14	PRP	_	_
28	give	_	VB	_	_	27	IM	_	_
29	it	_	PRP	_	_	28	OBJ	_	_
30	better	_	JJR	_	_	31	NMOD	_	_
31	balance	_	NN	_	_	28	OBJ	_	_
32	.	_	.	_	_	13	P	_	_

1	During	_	IN	_	_	8	TMP	_	_
2	the	_	DT	_	_	4	NMOD	_	_
3	same	_	JJ	_	_	4	NMOD	_	_
4	period	_	NN	_	_	1	PMOD	_	_
5	,	_	,	_	_	8	P	_	_
6	the	_	DT	_	_	7	NMOD	_	_
7	company	_	NN	_	_	8	SBJ	_	_
8	has	_	VBZ	_	_	0	ROOT	_	_
9	sold	_	VBN	_	_	8	VC	_	_
10	about	_	IN	_	_	12	DEP	_	_
11	1.6	_	CD	_	_	12	DEP	_	_
12	billion	_	CD	_	_	13	NMOD	_	_
13	guilders	_	NNS	_	_	9	OBJ	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	assets	_	NNS	_	_	14	PMOD	_	_
16	.	_	.	_	_	8	P	_	_

1	The	_	DT	_	_	3	NMOD	_	_
2	fibers	_	NNS	_	_	3	NMOD	_	_
3	business	_	NN	_	_	18	SBJ	_	_
4	,	_	,	_	_	3	P	_	_
5	whose	_	WP$	_	_	6	NMOD	_	_
6	products	_	NNS	_	_	7	SBJ	_	_
7	go	_	VBP	_	_	3	NMOD	_	_
8	into	_	IN	_	_	7	ADV	_	_
9	textiles	_	NNS	_	_	8	PMOD	_	_
10	,	_	,	_	_	9	P	_	_
11	carpeting	_	NN	_	_	9	COORD	_	_
12	and	_	CC	_	_	11	COORD	_	_
13	myriad	_	JJ	_	_	15	NMOD	_	_
14	industrial	_	JJ	_	_	15	NMOD	_	_
15	uses	_	NNS	_	_	12	CONJ	_	_
16	,	_	,	_	_	3	P	_	_
17	now	_	RB	_	_	18	TMP	_	_
18	accounts	_	VBZ	_	_	0	ROOT	_	_
19	for	_	IN	_	_	18	ADV	_	_
20	only	_	RB	_	_	22	NMOD	_	_
21	20	_	CD	_	_	20	DEP	_	_
22	%	_	NN	_	_	19	PMOD	_	_
23	of	_	IN	_	_	22	NMOD	_	_
24	Akzo	_	NNP	_	_	26	NMOD	_	_
25	's	_	POS	_	_	24	SUFFIX	_	_
26	sales	_	NNS	_	_	23	PMOD	_	_
27	.	_	.	_	_	18	P	_	_

1	``	_	``	_	_	17	P	_	_
2	We	_	PRP	_	_	3	SBJ	_	_
3	have	_	VBP	_	_	17	OBJ	_	_
4	definitely	_	RB	_	_	3	ADV	_	_
5	become	_	VBN	_	_	3	VC	_	_
6	less	_	RBR	_	_	7	AMOD	_	_
7	cyclical	_	JJ	_	_	5	PRD	_	_
8	,	_	,	_	_	17	P	_	_
9	''	_	''	_	_	17	P	_	_
10	Syb	_	NNP	_	_	11	NAME	_	_
11	Bergsma	_	NNP	_	_	17	SBJ	_	_
12	,	_	,	_	_	11	P	_	_
13	executive	_	JJ	_	_	15	NMOD	_	_
14	vice	_	NN	_	_	15	NMOD	_	_
15	president-finance	_	NN	_	_	11	APPO	_	_
16	,	_	,	_	_	11	P	_	_
17	said	_	VBD	_	_	0	ROOT	_	_
18	in	_	IN	_	_	17	LOC	_	_
19	an	_	DT	_	_	20	NMOD	_	_
20	interview	_	NN	_	_	18	PMOD	_	_
21	.	_	.	_	_	17	P	_	_

1	Still	_	RB	_	_	4	ADV	_	_
2	,	_	,	_	_	4	P	_	_
3	Akzo	_	NNP	_	_	4	SBJ	_	_
4	has	_	VBZ	_	_	0	ROOT	_	_
5	n't	_	RB	_	_	4	ADV	_	_
6	yet	_	RB	_	_	4	TMP	_	_
7	found	_	VBN	_	_	4	VC	_	_
8	a	_	DT	_	_	9	NMOD	_	_
9	way	_	NN	_	_	7	OBJ	_	_
10	to	_	TO	_	_	9	NMOD	_	_
11	achieve	_	VB	_	_	10	IM	_	_
12	another	_	DT	_	_	13	NMOD	_	_
13	goal	_	NN	_	_	11	OBJ	_	_
14	:	_	:	_	_	13	P	_	_
15	a	_	DT	_	_	17	NMOD	_	_
16	large	_	JJ	_	_	17	NMOD	_	_
17	presence	_	NN	_	_	13	APPO	_	_
18	in	_	IN	_	_	17	LOC	_	_
19	the	_	DT	_	_	21	NMOD	_	_
20	U.S.	_	NNP	_	_	21	NMOD	_	_
21	market	_	NN	_	_	18	PMOD	_	_
22	for	_	IN	_	_	21	NMOD	_	_
23	prescription	_	NN	_	_	24	NMOD	_	_
24	drugs	_	NNS	_	_	22	PMOD	_	_
25	.	_	.	_	_	4	P	_	_

1	Mr.	_	NNP	_	_	2	TITLE	_	_
2	Bergsma	_	NNP	_	_	3	SBJ	_	_
3	said	_	VBD	_	_	0	ROOT	_	_
4	prices	_	NNS	_	_	9	SBJ	_	_
5	for	_	IN	_	_	4	NMOD	_	_
6	U.S.	_	NNP	_	_	8	NMOD	_	_
7	pharmaceutical	_	JJ	_	_	8	NMOD	_	_
8	companies	_	NNS	_	_	5	PMOD	_	_
9	remain	_	VBP	_	_	3	OBJ	_	_
10	too	_	RB	_	_	11	AMOD	_	_
11	high	_	JJ	_	_	9	PRD	_	_
12	,	_	,	_	_	9	P	_	_
13	making	_	VBG	_	_	9	ADV	_	_
14	it	_	PRP	_	_	13	OBJ	_	_
15	unlikely	_	JJ	_	_	13	OPRD	_	_
16	that	_	IN	_	_	15	EXTR	_	_
17	Akzo	_	NNP	_	_	18	SBJ	_	_
18	will	_	MD	_	_	16	SUB	_	_
19	pursue	_	VB	_	_	18	VC	_	_
20	any	_	DT	_	_	22	NMOD	_	_
21	major	_	JJ	_	_	22	NMOD	_	_
22	acquisitions	_	NNS	_	_	19	OBJ	_	_
23	in	_	IN	_	_	19	LOC	_	_
24	that	_	DT	_	_	25	NMOD	_	_
25	area	_	NN	_	_	23	PMOD	_	_
26	.	_	.	_	_	3	P	_	_

1	But	_	CC	_	_	3	DEP	_	_
2	he	_	PRP	_	_	3	SBJ	_	_
3	said	_	VBD	_	_	0	ROOT	_	_
4	Akzo	_	NNP	_	_	5	SBJ	_	_
5	is	_	VBZ	_	_	3	OBJ	_	_
6	considering	_	VBG	_	_	5	VC	_	_
7	``	_	``	_	_	8	P	_	_
8	alliances	_	NNS	_	_	6	OBJ	_	_
9	''	_	''	_	_	8	P	_	_
10	with	_	IN	_	_	8	NMOD	_	_
11	American	_	JJ	_	_	13	NMOD	_	_
12	drug	_	NN	_	_	13	NMOD	_	_
13	companies	_	NNS	_	_	10	PMOD	_	_
14	,	_	,	_	_	3	P	_	_
15	although	_	IN	_	_	3	ADV	_	_
16	he	_	PRP	_	_	17	SBJ	_	_
17	would	_	MD	_	_	15	SUB	_	_
18	n't	_	RB	_	_	17	ADV	_	_
19	elaborate	_	VB	_	_	17	VC	_	_
20	.	_	.	_	_	3	P	_	_

1	An	_	DT	_	_	2	NMOD	_	_
2	indication	_	NN	_	_	10	SBJ	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	Akzo	_	NNP	_	_	6	NMOD	_	_
5	's	_	POS	_	_	4	SUFFIX	_	_
6	success	_	NN	_	_	3	PMOD	_	_
7	in	_	IN	_	_	6	NMOD	_	_
8	reshaping	_	VBG	_	_	7	PMOD	_	_
9	itself	_	PRP	_	_	8	OBJ	_	_
10	will	_	MD	_	_	0	ROOT	_	_
11	come	_	VB	_	_	10	VC	_	_
12	Thursday	_	NNP	_	_	11	TMP	_	_
13	when	_	WRB	_	_	15	TMP	_	_
14	it	_	PRP	_	_	15	SBJ	_	_
15	reports	_	VBZ	_	_	11	TMP	_	_
16	third-quarter	_	NN	_	_	17	NMOD	_	_
17	results	_	NNS	_	_	15	OBJ	_	_
18	.	_	.	_	_	10	P	_	_

1	Analysts	_	NNS	_	_	2	SBJ	_	_
2	expect	_	VBP	_	_	0	ROOT	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	company	_	NN	_	_	2	OBJ	_	_
5	to	_	TO	_	_	2	OPRD	_	_
6	show	_	VB	_	_	5	IM	_	_
7	profit	_	NN	_	_	6	OBJ	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	about	_	IN	_	_	11	DEP	_	_
10	225	_	CD	_	_	11	DEP	_	_
11	million	_	CD	_	_	12	NMOD	_	_
12	guilders	_	NNS	_	_	8	PMOD	_	_
13	,	_	,	_	_	12	P	_	_
14	up	_	RB	_	_	12	NMOD	_	_
15	9	_	CD	_	_	16	NMOD	_	_
16	%	_	NN	_	_	14	AMOD	_	_
17	from	_	IN	_	_	14	AMOD	_	_
18	206.3	_	CD	_	_	19	DEP	_	_
19	million	_	CD	_	_	20	NMOD	_	_
20	guilders	_	NNS	_	_	17	PMOD	_	_
21	a	_	DT	_	_	22	NMOD	_	_
22	year	_	NN	_	_	23	AMOD	_	_
23	earlier	_	RBR	_	_	17	TMP	_	_
24	.	_	.	_	_	2	P	_	_

1	A	_	DT	_	_	3	NMOD	_	_
2	bigger	_	JJR	_	_	3	NMOD	_	_
3	test	_	NN	_	_	4	SBJ	_	_
4	will	_	MD	_	_	0	ROOT	_	_
5	come	_	VB	_	_	4	VC	_	_
6	next	_	JJ	_	_	7	NMOD	_	_
7	year	_	NN	_	_	5	TMP	_	_
8	if	_	IN	_	_	5	ADV	_	_
9	,	_	,	_	_	8	P	_	_
10	as	_	IN	_	_	18	ADV	_	_
11	many	_	JJ	_	_	12	NMOD	_	_
12	analysts	_	NNS	_	_	13	SBJ	_	_
13	expect	_	VBP	_	_	10	SUB	_	_
14	,	_	,	_	_	18	P	_	_
15	bulk	_	JJ	_	_	17	NMOD	_	_
16	chemical	_	NN	_	_	17	NMOD	_	_
17	prices	_	NNS	_	_	18	SBJ	_	_
18	slump	_	VBP	_	_	8	SUB	_	_
19	in	_	IN	_	_	18	LOC	_	_
20	Europe	_	NNP	_	_	19	PMOD	_	_
21	.	_	.	_	_	4	P	_	_

1	``	_	``	_	_	13	P	_	_
2	Maybe	_	RB	_	_	4	ADV	_	_
3	Akzo	_	NNP	_	_	4	SBJ	_	_
4	can	_	MD	_	_	13	OBJ	_	_
5	surprise	_	VB	_	_	4	VC	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	investment	_	NN	_	_	8	NMOD	_	_
8	world	_	NN	_	_	5	OBJ	_	_
9	a	_	DT	_	_	10	NMOD	_	_
10	bit	_	NN	_	_	5	ADV	_	_
11	,	_	,	_	_	13	P	_	_
12	''	_	''	_	_	13	P	_	_
13	said	_	VBD	_	_	0	ROOT	_	_
14	Jaap	_	NNP	_	_	15	NAME	_	_
15	Visker	_	NNP	_	_	13	SBJ	_	_
16	,	_	,	_	_	15	P	_	_
17	an	_	DT	_	_	18	NMOD	_	_
18	analyst	_	NN	_	_	15	APPO	_	_
19	at	_	IN	_	_	18	LOC	_	_
20	Amsterdam-Rotterdam	_	NNP	_	_	22	NAME	_	_
21	Bank	_	NNP	_	_	22	NAME	_	_
22	NV	_	NNP	_	_	19	PMOD	_	_
23	.	_	.	_	_	13	P	_	_

1	He	_	PRP	_	_	2	SBJ	_	_
2	figures	_	VBZ	_	_	0	ROOT	_	_
3	Akzo	_	NNP	_	_	4	SBJ	_	_
4	is	_	VBZ	_	_	2	OBJ	_	_
5	likely	_	JJ	_	_	4	PRD	_	_
6	to	_	TO	_	_	5	AMOD	_	_
7	be	_	VB	_	_	6	IM	_	_
8	one	_	CD	_	_	7	PRD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	the	_	DT	_	_	14	NMOD	_	_
11	few	_	JJ	_	_	14	NMOD	_	_
12	major	_	JJ	_	_	14	NMOD	_	_
13	chemical	_	NN	_	_	14	NMOD	_	_
14	companies	_	NNS	_	_	9	PMOD	_	_
15	to	_	TO	_	_	8	NMOD	_	_
16	show	_	VB	_	_	15	IM	_	_
17	profit	_	NN	_	_	18	NMOD	_	_
18	growth	_	NN	_	_	16	OBJ	_	_
19	next	_	IN	_	_	20	NMOD	_	_
20	year	_	NN	_	_	16	TMP	_	_
21	.	_	.	_	_	2	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	bank	_	NN	_	_	3	SBJ	_	_
3	projects	_	VBZ	_	_	0	ROOT	_	_
4	Akzo	_	NNP	_	_	5	SBJ	_	_
5	will	_	MD	_	_	3	OBJ	_	_
6	show	_	VB	_	_	5	VC	_	_
7	per-share	_	JJ	_	_	8	NMOD	_	_
8	earnings	_	NNS	_	_	6	OBJ	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	24	_	CD	_	_	11	NMOD	_	_
11	guilders	_	NNS	_	_	9	PMOD	_	_
12	in	_	IN	_	_	6	TMP	_	_
13	1990	_	CD	_	_	12	PMOD	_	_
14	,	_	,	_	_	6	P	_	_
15	up	_	RB	_	_	6	ADV	_	_
16	from	_	IN	_	_	15	AMOD	_	_
17	an	_	DT	_	_	20	NMOD	_	_
18	estimated	_	VBN	_	_	20	NMOD	_	_
19	22.5	_	CD	_	_	20	NMOD	_	_
20	guilders	_	NNS	_	_	16	PMOD	_	_
21	for	_	IN	_	_	20	NMOD	_	_
22	this	_	DT	_	_	23	NMOD	_	_
23	year	_	NN	_	_	21	PMOD	_	_
24	and	_	CC	_	_	20	COORD	_	_
25	the	_	DT	_	_	27	NMOD	_	_
26	20.9	_	CD	_	_	27	NMOD	_	_
27	guilders	_	NNS	_	_	24	CONJ	_	_
28	reported	_	VBN	_	_	27	APPO	_	_
29	for	_	IN	_	_	28	ADV	_	_
30	1988	_	CD	_	_	29	PMOD	_	_
31	.	_	.	_	_	3	P	_	_

1	At	_	IN	_	_	12	LOC	_	_
2	James	_	NNP	_	_	3	NAME	_	_
3	Capel	_	NNP	_	_	1	PMOD	_	_
4	&	_	CC	_	_	3	COORD	_	_
5	Co.	_	NNP	_	_	4	CONJ	_	_
6	in	_	IN	_	_	3	LOC	_	_
7	London	_	NNP	_	_	6	PMOD	_	_
8	,	_	,	_	_	12	P	_	_
9	analyst	_	NN	_	_	11	NMOD	_	_
10	Jackie	_	NNP	_	_	11	NAME	_	_
11	Ashurst	_	NNP	_	_	12	SBJ	_	_
12	notes	_	VBZ	_	_	0	ROOT	_	_
13	that	_	IN	_	_	12	OBJ	_	_
14	Akzo	_	NNP	_	_	15	SBJ	_	_
15	is	_	VBZ	_	_	13	SUB	_	_
16	less	_	RBR	_	_	17	AMOD	_	_
17	exposed	_	VBN	_	_	15	PRD	_	_
18	than	_	IN	_	_	17	AMOD	_	_
19	many	_	JJ	_	_	18	PMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	its	_	PRP$	_	_	22	NMOD	_	_
22	rivals	_	NNS	_	_	20	PMOD	_	_
23	to	_	TO	_	_	17	AMOD	_	_
24	the	_	DT	_	_	28	NMOD	_	_
25	most	_	RBS	_	_	26	AMOD	_	_
26	volatile	_	JJ	_	_	28	NMOD	_	_
27	chemical	_	NN	_	_	28	NMOD	_	_
28	products	_	NNS	_	_	23	PMOD	_	_
29	.	_	.	_	_	12	P	_	_

1	For	_	IN	_	_	5	ADV	_	_
2	example	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	5	P	_	_
4	Akzo	_	NNP	_	_	5	SBJ	_	_
5	has	_	VBZ	_	_	0	ROOT	_	_
6	only	_	RB	_	_	5	ADV	_	_
7	minor	_	JJ	_	_	9	NMOD	_	_
8	petrochemical	_	NN	_	_	9	NMOD	_	_
9	operations	_	NNS	_	_	5	OBJ	_	_
10	,	_	,	_	_	5	P	_	_
11	is	_	VBZ	_	_	5	COORD	_	_
12	small	_	JJ	_	_	11	PRD	_	_
13	in	_	IN	_	_	11	LOC	_	_
14	plastics	_	NNS	_	_	13	PMOD	_	_
15	and	_	CC	_	_	11	COORD	_	_
16	does	_	VBZ	_	_	15	CONJ	_	_
17	n't	_	RB	_	_	16	ADV	_	_
18	make	_	VB	_	_	16	VC	_	_
19	fertilizers	_	NNS	_	_	18	OBJ	_	_
20	.	_	.	_	_	5	P	_	_

1	Thus	_	RB	_	_	22	ADV	_	_
2	,	_	,	_	_	22	P	_	_
3	while	_	IN	_	_	22	ADV	_	_
4	Akzo	_	NNP	_	_	5	SBJ	_	_
5	profited	_	VBD	_	_	3	SUB	_	_
6	less	_	JJR	_	_	5	ADV	_	_
7	than	_	IN	_	_	6	AMOD	_	_
8	many	_	JJ	_	_	9	NMOD	_	_
9	rivals	_	NNS	_	_	7	PMOD	_	_
10	from	_	IN	_	_	5	ADV	_	_
11	the	_	DT	_	_	12	NMOD	_	_
12	boom	_	NN	_	_	10	PMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	recent	_	JJ	_	_	15	NMOD	_	_
15	years	_	NNS	_	_	13	PMOD	_	_
16	in	_	IN	_	_	12	LOC	_	_
17	petrochemicals	_	NNS	_	_	16	PMOD	_	_
18	and	_	CC	_	_	17	COORD	_	_
19	plastics	_	NNS	_	_	18	CONJ	_	_
20	,	_	,	_	_	22	P	_	_
21	it	_	PRP	_	_	22	SBJ	_	_
22	has	_	VBZ	_	_	0	ROOT	_	_
23	less	_	JJR	_	_	22	OBJ	_	_
24	to	_	TO	_	_	23	NMOD	_	_
25	fear	_	VB	_	_	24	IM	_	_
26	from	_	IN	_	_	25	ADV	_	_
27	the	_	DT	_	_	29	NMOD	_	_
28	current	_	JJ	_	_	29	NMOD	_	_
29	slump	_	NN	_	_	26	PMOD	_	_
30	.	_	.	_	_	22	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	company	_	NN	_	_	3	SBJ	_	_
3	is	_	VBZ	_	_	0	ROOT	_	_
4	exposed	_	VBN	_	_	3	VC	_	_
5	to	_	TO	_	_	4	ADV	_	_
6	bulk	_	NN	_	_	7	NMOD	_	_
7	chemicals	_	NNS	_	_	5	PMOD	_	_
8	,	_	,	_	_	4	P	_	_
9	however	_	RB	_	_	4	ADV	_	_
10	.	_	.	_	_	3	P	_	_

1	Although	_	IN	_	_	12	ADV	_	_
2	bulk-chemical	_	JJ	_	_	3	NMOD	_	_
3	prices	_	NNS	_	_	4	SBJ	_	_
4	have	_	VBP	_	_	1	SUB	_	_
5	begun	_	VBN	_	_	4	VC	_	_
6	falling	_	VBG	_	_	5	OPRD	_	_
7	in	_	IN	_	_	5	LOC	_	_
8	the	_	DT	_	_	9	NMOD	_	_
9	U.S.	_	NNP	_	_	7	PMOD	_	_
10	,	_	,	_	_	12	P	_	_
11	they	_	PRP	_	_	12	SBJ	_	_
12	are	_	VBP	_	_	20	OBJ	_	_
13	generally	_	RB	_	_	12	ADV	_	_
14	stable	_	JJ	_	_	12	PRD	_	_
15	in	_	IN	_	_	12	LOC	_	_
16	Europe	_	NNP	_	_	15	PMOD	_	_
17	,	_	,	_	_	20	P	_	_
18	Mr.	_	NNP	_	_	19	TITLE	_	_
19	Bergsma	_	NNP	_	_	20	SBJ	_	_
20	said	_	VBD	_	_	0	ROOT	_	_
21	.	_	.	_	_	20	P	_	_

1	A	_	DT	_	_	2	NMOD	_	_
2	decline	_	NN	_	_	3	SBJ	_	_
3	may	_	MD	_	_	13	OBJ	_	_
4	come	_	VB	_	_	3	VC	_	_
5	in	_	IN	_	_	4	TMP	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	first	_	JJ	_	_	8	NMOD	_	_
8	half	_	NN	_	_	5	PMOD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	1990	_	CD	_	_	9	PMOD	_	_
11	,	_	,	_	_	13	P	_	_
12	he	_	PRP	_	_	13	SBJ	_	_
13	said	_	VBD	_	_	0	ROOT	_	_
14	,	_	,	_	_	13	P	_	_
15	but	_	CC	_	_	3	COORD	_	_
16	the	_	DT	_	_	17	NMOD	_	_
17	market	_	NN	_	_	18	SBJ	_	_
18	does	_	VBZ	_	_	15	CONJ	_	_
19	n't	_	RB	_	_	18	ADV	_	_
20	appear	_	VB	_	_	18	VC	_	_
21	on	_	IN	_	_	20	LOC-PRD	_	_
22	the	_	DT	_	_	23	NMOD	_	_
23	verge	_	NN	_	_	21	PMOD	_	_
24	of	_	IN	_	_	23	NMOD	_	_
25	a	_	DT	_	_	27	NMOD	_	_
26	severe	_	JJ	_	_	27	NMOD	_	_
27	downturn	_	NN	_	_	24	PMOD	_	_
28	.	_	.	_	_	3	P	_	_

1	To	_	TO	_	_	11	PRP	_	_
2	reduce	_	VB	_	_	1	IM	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	danger	_	NN	_	_	2	OBJ	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	such	_	JJ	_	_	8	NMOD	_	_
7	pricing	_	NN	_	_	8	NMOD	_	_
8	cycles	_	NNS	_	_	5	PMOD	_	_
9	,	_	,	_	_	11	P	_	_
10	Akzo	_	NNP	_	_	11	SBJ	_	_
11	has	_	VBZ	_	_	0	ROOT	_	_
12	invested	_	VBN	_	_	11	VC	_	_
13	heavily	_	RB	_	_	12	MNR	_	_
14	in	_	IN	_	_	12	ADV	_	_
15	specialty	_	NN	_	_	16	NMOD	_	_
16	chemicals	_	NNS	_	_	14	PMOD	_	_
17	,	_	,	_	_	16	P	_	_
18	which	_	WDT	_	_	19	SBJ	_	_
19	have	_	VBP	_	_	16	NMOD	_	_
20	highly	_	RB	_	_	21	AMOD	_	_
21	specific	_	JJ	_	_	23	NMOD	_	_
22	industrial	_	JJ	_	_	23	NMOD	_	_
23	uses	_	NNS	_	_	19	OBJ	_	_
24	and	_	CC	_	_	19	COORD	_	_
25	tend	_	VBP	_	_	24	CONJ	_	_
26	to	_	TO	_	_	25	OPRD	_	_
27	produce	_	VB	_	_	26	IM	_	_
28	much	_	JJ	_	_	31	NMOD	_	_
29	higher	_	JJR	_	_	28	AMOD	_	_
30	profit	_	NN	_	_	31	NMOD	_	_
31	margins	_	NNS	_	_	27	OBJ	_	_
32	than	_	IN	_	_	31	NMOD	_	_
33	do	_	VBP	_	_	32	SUB	_	_
34	bulk	_	JJ	_	_	35	NMOD	_	_
35	chemicals	_	NNS	_	_	33	SBJ	_	_
36	.	_	.	_	_	11	P	_	_

1	Akzo	_	NNP	_	_	4	NMOD	_	_
2	's	_	POS	_	_	1	SUFFIX	_	_
3	biggest	_	JJS	_	_	4	NMOD	_	_
4	move	_	NN	_	_	8	SBJ	_	_
5	in	_	IN	_	_	4	LOC	_	_
6	this	_	DT	_	_	7	NMOD	_	_
7	area	_	NN	_	_	5	PMOD	_	_
8	was	_	VBD	_	_	0	ROOT	_	_
9	the	_	DT	_	_	11	NMOD	_	_
10	1987	_	CD	_	_	11	NMOD	_	_
11	acquisition	_	NN	_	_	8	PRD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	Stauffer	_	NNP	_	_	15	NAME	_	_
14	Chemical	_	NNP	_	_	15	NAME	_	_
15	Co.	_	NNP	_	_	19	NMOD	_	_
16	's	_	POS	_	_	15	SUFFIX	_	_
17	specialty	_	NN	_	_	19	NMOD	_	_
18	chemical	_	NN	_	_	19	NMOD	_	_
19	business	_	NN	_	_	12	PMOD	_	_
20	for	_	IN	_	_	11	NMOD	_	_
21	$	_	$	_	_	20	PMOD	_	_
22	625	_	CD	_	_	21	DEP	_	_
23	million	_	CD	_	_	21	DEP	_	_
24	.	_	.	_	_	8	P	_	_

1	In	_	IN	_	_	8	LOC	_	_
2	a	_	DT	_	_	5	NMOD	_	_
3	less	_	RBR	_	_	4	AMOD	_	_
4	glamorous	_	JJ	_	_	5	NMOD	_	_
5	field	_	NN	_	_	1	PMOD	_	_
6	,	_	,	_	_	8	P	_	_
7	Akzo	_	NNP	_	_	8	SBJ	_	_
8	is	_	VBZ	_	_	0	ROOT	_	_
9	the	_	DT	_	_	10	NMOD	_	_
10	world	_	NN	_	_	13	NMOD	_	_
11	's	_	POS	_	_	10	SUFFIX	_	_
12	biggest	_	JJS	_	_	13	NMOD	_	_
13	producer	_	NN	_	_	8	PRD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	industrial	_	JJ	_	_	16	NMOD	_	_
16	salt	_	NN	_	_	14	PMOD	_	_
17	,	_	,	_	_	16	P	_	_
18	used	_	VBD	_	_	16	APPO	_	_
19	as	_	IN	_	_	18	ADV	_	_
20	a	_	DT	_	_	22	NMOD	_	_
21	raw	_	JJ	_	_	22	NMOD	_	_
22	material	_	NN	_	_	19	PMOD	_	_
23	for	_	IN	_	_	22	NMOD	_	_
24	the	_	DT	_	_	26	NMOD	_	_
25	chemical	_	JJ	_	_	26	NMOD	_	_
26	industry	_	NN	_	_	23	PMOD	_	_
27	as	_	RB	_	_	19	COORD	_	_
28	well	_	RB	_	_	27	DEP	_	_
29	as	_	IN	_	_	27	DEP	_	_
30	for	_	IN	_	_	27	CONJ	_	_
31	such	_	JJ	_	_	32	NMOD	_	_
32	tasks	_	NNS	_	_	30	PMOD	_	_
33	as	_	IN	_	_	32	NMOD	_	_
34	melting	_	VBG	_	_	33	PMOD	_	_
35	ice	_	NN	_	_	34	OBJ	_	_
36	.	_	.	_	_	8	P	_	_

1	Akzo	_	NNP	_	_	3	SBJ	_	_
2	also	_	RB	_	_	3	ADV	_	_
3	makes	_	VBZ	_	_	0	ROOT	_	_
4	products	_	NNS	_	_	3	OBJ	_	_
5	derived	_	VBN	_	_	4	APPO	_	_
6	from	_	IN	_	_	5	ADV	_	_
7	salt	_	NN	_	_	6	PMOD	_	_
8	,	_	,	_	_	4	P	_	_
9	such	_	JJ	_	_	10	DEP	_	_
10	as	_	IN	_	_	4	NMOD	_	_
11	chlorine	_	NN	_	_	10	PMOD	_	_
12	and	_	CC	_	_	11	COORD	_	_
13	caustic	_	JJ	_	_	14	NMOD	_	_
14	soda	_	NN	_	_	12	CONJ	_	_
15	.	_	.	_	_	3	P	_	_

1	In	_	IN	_	_	7	LOC	_	_
2	the	_	DT	_	_	4	NMOD	_	_
3	fibers	_	NNS	_	_	4	NMOD	_	_
4	division	_	NN	_	_	1	PMOD	_	_
5	,	_	,	_	_	7	P	_	_
6	profit	_	NN	_	_	7	SBJ	_	_
7	remains	_	VBZ	_	_	0	ROOT	_	_
8	weak	_	JJ	_	_	7	PRD	_	_
9	,	_	,	_	_	7	P	_	_
10	largely	_	RB	_	_	11	PMOD	_	_
11	because	_	IN	_	_	7	PRP	_	_
12	of	_	IN	_	_	11	DEP	_	_
13	persistent	_	JJ	_	_	14	NMOD	_	_
14	overcapacity	_	NN	_	_	11	PMOD	_	_
15	.	_	.	_	_	7	P	_	_

1	But	_	CC	_	_	3	DEP	_	_
2	Akzo	_	NNP	_	_	3	SBJ	_	_
3	is	_	VBZ	_	_	0	ROOT	_	_
4	still	_	RB	_	_	3	TMP	_	_
5	slimming	_	VBG	_	_	3	VC	_	_
6	down	_	IN	_	_	5	PRT	_	_
7	:	_	:	_	_	3	P	_	_
8	It	_	PRP	_	_	10	SBJ	_	_
9	recently	_	RB	_	_	10	TMP	_	_
10	announced	_	VBD	_	_	3	COORD	_	_
11	plans	_	NNS	_	_	10	OBJ	_	_
12	to	_	TO	_	_	11	NMOD	_	_
13	eliminate	_	VB	_	_	12	IM	_	_
14	about	_	IN	_	_	15	DEP	_	_
15	1,700	_	CD	_	_	17	NMOD	_	_
16	fiber-related	_	JJ	_	_	17	NMOD	_	_
17	jobs	_	NNS	_	_	13	OBJ	_	_
18	in	_	IN	_	_	17	LOC	_	_
19	the	_	DT	_	_	20	NMOD	_	_
20	Netherlands	_	NNP	_	_	18	PMOD	_	_
21	and	_	CC	_	_	20	COORD	_	_
22	West	_	NNP	_	_	23	NAME	_	_
23	Germany	_	NNP	_	_	21	CONJ	_	_
24	.	_	.	_	_	3	P	_	_

1	Although	_	IN	_	_	12	ADV	_	_
2	the	_	DT	_	_	3	NMOD	_	_
3	polyester	_	NN	_	_	7	SBJ	_	_
4	and	_	CC	_	_	3	COORD	_	_
5	rayon	_	NN	_	_	6	NMOD	_	_
6	markets	_	NNS	_	_	4	CONJ	_	_
7	remain	_	VBP	_	_	1	SUB	_	_
8	mostly	_	RB	_	_	9	AMOD	_	_
9	bleak	_	JJ	_	_	7	PRD	_	_
10	,	_	,	_	_	12	P	_	_
11	Akzo	_	NNP	_	_	12	SBJ	_	_
12	has	_	VBZ	_	_	0	ROOT	_	_
13	high	_	JJ	_	_	14	NMOD	_	_
14	hopes	_	NNS	_	_	12	OBJ	_	_
15	for	_	IN	_	_	14	NMOD	_	_
16	some	_	DT	_	_	19	NMOD	_	_
17	emerging	_	VBG	_	_	19	NMOD	_	_
18	fiber	_	NN	_	_	19	NMOD	_	_
19	businesses	_	NNS	_	_	15	PMOD	_	_
20	,	_	,	_	_	19	P	_	_
21	such	_	JJ	_	_	19	APPO	_	_
22	carbon	_	NN	_	_	23	NMOD	_	_
23	fibers	_	NNS	_	_	21	AMOD	_	_
24	and	_	CC	_	_	23	COORD	_	_
25	aramid	_	NN	_	_	24	CONJ	_	_
26	,	_	,	_	_	23	P	_	_
27	extremely	_	RB	_	_	28	AMOD	_	_
28	strong	_	JJ	_	_	29	NMOD	_	_
29	fibers	_	NNS	_	_	23	APPO	_	_
30	used	_	VBN	_	_	29	APPO	_	_
31	to	_	TO	_	_	30	OPRD	_	_
32	reinforce	_	VB	_	_	31	IM	_	_
33	tires	_	NNS	_	_	32	OBJ	_	_
34	and	_	CC	_	_	33	COORD	_	_
35	metals	_	NNS	_	_	34	CONJ	_	_
36	and	_	CC	_	_	31	COORD	_	_
37	to	_	TO	_	_	36	CONJ	_	_
38	make	_	VB	_	_	37	IM	_	_
39	such	_	JJ	_	_	40	NMOD	_	_
40	products	_	NNS	_	_	38	OBJ	_	_
41	as	_	IN	_	_	40	NMOD	_	_
42	bullet-proof	_	JJ	_	_	43	NMOD	_	_
43	vests	_	NNS	_	_	41	PMOD	_	_
44	.	_	.	_	_	12	P	_	_

1	Akzo	_	NNP	_	_	5	NMOD	_	_
2	's	_	POS	_	_	1	SUFFIX	_	_
3	Twaron	_	NNP	_	_	5	NMOD	_	_
4	aramid	_	NN	_	_	5	NMOD	_	_
5	fiber	_	NN	_	_	6	SBJ	_	_
6	is	_	VBZ	_	_	0	ROOT	_	_
7	a	_	DT	_	_	9	NMOD	_	_
8	distant	_	JJ	_	_	9	NMOD	_	_
9	second	_	NN	_	_	6	PRD	_	_
10	to	_	TO	_	_	9	NMOD	_	_
11	Du	_	NNP	_	_	13	NAME	_	_
12	Pont	_	NNP	_	_	13	NAME	_	_
13	Co.	_	NNP	_	_	15	NMOD	_	_
14	's	_	POS	_	_	13	SUFFIX	_	_
15	Kevlar	_	NNP	_	_	10	PMOD	_	_
16	,	_	,	_	_	15	P	_	_
17	which	_	WDT	_	_	18	SBJ	_	_
18	dominates	_	VBZ	_	_	15	NMOD	_	_
19	the	_	DT	_	_	20	NMOD	_	_
20	market	_	NN	_	_	18	OBJ	_	_
21	.	_	.	_	_	6	P	_	_

1	Mr.	_	NNP	_	_	2	TITLE	_	_
2	Bergsma	_	NNP	_	_	3	SBJ	_	_
3	said	_	VBD	_	_	0	ROOT	_	_
4	world-wide	_	JJ	_	_	6	NMOD	_	_
5	industry	_	NN	_	_	6	NMOD	_	_
6	sales	_	NNS	_	_	10	SBJ	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	aramid	_	NN	_	_	9	NMOD	_	_
9	fibers	_	NNS	_	_	7	PMOD	_	_
10	are	_	VBP	_	_	3	OBJ	_	_
11	expected	_	VBN	_	_	10	VC	_	_
12	to	_	TO	_	_	11	OPRD	_	_
13	total	_	VB	_	_	12	IM	_	_
14	about	_	IN	_	_	15	DEP	_	_
15	$	_	$	_	_	13	OBJ	_	_
16	500	_	CD	_	_	15	DEP	_	_
17	million	_	CD	_	_	15	DEP	_	_
18	this	_	DT	_	_	19	NMOD	_	_
19	year	_	NN	_	_	13	TMP	_	_
20	.	_	.	_	_	3	P	_	_

1	Sales	_	NNS	_	_	2	NMOD	_	_
2	growth	_	NN	_	_	8	SBJ	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	10	_	CD	_	_	5	NMOD	_	_
5	%	_	NN	_	_	3	PMOD	_	_
6	a	_	DT	_	_	7	NMOD	_	_
7	year	_	NN	_	_	5	ADV	_	_
8	seems	_	VBZ	_	_	12	OBJ	_	_
9	possible	_	JJ	_	_	8	PRD	_	_
10	,	_	,	_	_	12	P	_	_
11	he	_	PRP	_	_	12	SBJ	_	_
12	said	_	VBD	_	_	0	ROOT	_	_
13	,	_	,	_	_	12	P	_	_
14	and	_	CC	_	_	8	COORD	_	_
15	Akzo	_	NNP	_	_	16	SBJ	_	_
16	expects	_	VBZ	_	_	14	CONJ	_	_
17	its	_	PRP$	_	_	19	NMOD	_	_
18	Twaron	_	NNP	_	_	19	NMOD	_	_
19	business	_	NN	_	_	16	OBJ	_	_
20	to	_	TO	_	_	16	OPRD	_	_
21	become	_	VB	_	_	20	IM	_	_
22	profitable	_	JJ	_	_	21	PRD	_	_
23	in	_	IN	_	_	21	TMP	_	_
24	1990	_	CD	_	_	23	PMOD	_	_
25	.	_	.	_	_	8	P	_	_

1	Akzo	_	NNP	_	_	3	SBJ	_	_
2	also	_	RB	_	_	3	ADV	_	_
3	has	_	VBZ	_	_	0	ROOT	_	_
4	spent	_	VBN	_	_	3	VC	_	_
5	heavily	_	RB	_	_	4	MNR	_	_
6	on	_	IN	_	_	4	ADV	_	_
7	acquisitions	_	NNS	_	_	6	PMOD	_	_
8	in	_	IN	_	_	7	LOC	_	_
9	paints	_	NNS	_	_	8	PMOD	_	_
10	,	_	,	_	_	9	P	_	_
11	auto	_	NN	_	_	12	NMOD	_	_
12	finishes	_	NNS	_	_	9	COORD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	industrial	_	JJ	_	_	15	NMOD	_	_
15	coatings	_	NNS	_	_	13	CONJ	_	_
16	.	_	.	_	_	3	P	_	_

1	In	_	IN	_	_	8	TMP	_	_
2	August	_	NNP	_	_	1	PMOD	_	_
3	,	_	,	_	_	8	P	_	_
4	for	_	IN	_	_	8	ADV	_	_
5	example	_	NN	_	_	4	PMOD	_	_
6	,	_	,	_	_	8	P	_	_
7	it	_	PRP	_	_	8	SBJ	_	_
8	completed	_	VBD	_	_	0	ROOT	_	_
9	the	_	DT	_	_	13	NMOD	_	_
10	$	_	$	_	_	13	NMOD	_	_
11	110	_	CD	_	_	10	DEP	_	_
12	million	_	CD	_	_	10	DEP	_	_
13	acquisition	_	NN	_	_	8	OBJ	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	Reliance	_	NNP	_	_	16	NAME	_	_
16	Universal	_	NNP	_	_	14	PMOD	_	_
17	Inc.	_	NNP	_	_	16	POSTHON	_	_
18	,	_	,	_	_	16	P	_	_
19	a	_	DT	_	_	21	NMOD	_	_
20	U.S.	_	NNP	_	_	21	NMOD	_	_
21	maker	_	NN	_	_	16	APPO	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	industrial	_	JJ	_	_	24	NMOD	_	_
24	coatings	_	NNS	_	_	22	PMOD	_	_
25	for	_	IN	_	_	24	NMOD	_	_
26	wood	_	NN	_	_	25	PMOD	_	_
27	,	_	,	_	_	26	P	_	_
28	metals	_	NNS	_	_	26	COORD	_	_
29	and	_	CC	_	_	28	COORD	_	_
30	plastics	_	NNS	_	_	29	CONJ	_	_
31	,	_	,	_	_	13	P	_	_
32	from	_	IN	_	_	13	NMOD	_	_
33	Tyler	_	NNP	_	_	32	PMOD	_	_
34	Corp	_	NNP	_	_	33	POSTHON	_	_
35	.	_	.	_	_	8	P	_	_

1	Mr.	_	NNP	_	_	2	TITLE	_	_
2	Bergsma	_	NNP	_	_	3	SBJ	_	_
3	said	_	VBD	_	_	0	ROOT	_	_
4	Akzo	_	NNP	_	_	5	SBJ	_	_
5	is	_	VBZ	_	_	3	OBJ	_	_
6	likely	_	JJ	_	_	5	PRD	_	_
7	to	_	TO	_	_	6	AMOD	_	_
8	see	_	VB	_	_	7	IM	_	_
9	strong	_	JJ	_	_	11	NMOD	_	_
10	profit	_	NN	_	_	11	NMOD	_	_
11	growth	_	NN	_	_	8	OBJ	_	_
12	from	_	IN	_	_	11	NMOD	_	_
13	coatings	_	NNS	_	_	12	PMOD	_	_
14	as	_	IN	_	_	5	TMP	_	_
15	it	_	PRP	_	_	16	SBJ	_	_
16	realizes	_	VBZ	_	_	14	SUB	_	_
17	cost	_	NN	_	_	18	NMOD	_	_
18	savings	_	NNS	_	_	16	OBJ	_	_
19	and	_	CC	_	_	18	COORD	_	_
20	other	_	JJ	_	_	21	NMOD	_	_
21	benefits	_	NNS	_	_	19	CONJ	_	_
22	from	_	IN	_	_	21	NMOD	_	_
23	its	_	PRP$	_	_	25	NMOD	_	_
24	greater	_	JJR	_	_	25	NMOD	_	_
25	scale	_	NN	_	_	22	PMOD	_	_
26	.	_	.	_	_	3	P	_	_

1	For	_	IN	_	_	21	ADV	_	_
2	Akzo	_	NNP	_	_	5	NMOD	_	_
3	's	_	POS	_	_	2	SUFFIX	_	_
4	drug	_	NN	_	_	5	NMOD	_	_
5	business	_	NN	_	_	1	PMOD	_	_
6	,	_	,	_	_	5	P	_	_
7	where	_	WRB	_	_	10	LOC	_	_
8	profits	_	NNS	_	_	9	SBJ	_	_
9	have	_	VBP	_	_	5	NMOD	_	_
10	shown	_	VBN	_	_	9	VC	_	_
11	litle	_	JJ	_	_	12	NMOD	_	_
12	change	_	NN	_	_	10	OBJ	_	_
13	for	_	IN	_	_	10	TMP	_	_
14	the	_	DT	_	_	17	NMOD	_	_
15	past	_	JJ	_	_	17	NMOD	_	_
16	five	_	CD	_	_	17	NMOD	_	_
17	years	_	NNS	_	_	13	PMOD	_	_
18	,	_	,	_	_	21	P	_	_
19	Mr.	_	NNP	_	_	20	TITLE	_	_
20	Bergsma	_	NNP	_	_	21	SBJ	_	_
21	predicted	_	VBD	_	_	0	ROOT	_	_
22	moderate	_	JJ	_	_	24	NMOD	_	_
23	profit	_	NN	_	_	24	NMOD	_	_
24	growth	_	NN	_	_	21	OBJ	_	_
25	.	_	.	_	_	21	P	_	_

1	Akzo	_	NNP	_	_	2	SBJ	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	the	_	DT	_	_	5	NMOD	_	_
4	leading	_	VBG	_	_	5	NMOD	_	_
5	seller	_	NN	_	_	2	PRD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	birth-control	_	JJ	_	_	8	NMOD	_	_
8	pills	_	NNS	_	_	6	PMOD	_	_
9	in	_	IN	_	_	2	LOC	_	_
10	Europe	_	NNP	_	_	9	PMOD	_	_
11	but	_	CC	_	_	2	COORD	_	_
12	is	_	VBZ	_	_	11	CONJ	_	_
13	still	_	RB	_	_	12	TMP	_	_
14	seeking	_	VBG	_	_	12	VC	_	_
15	regulatory	_	JJ	_	_	16	NMOD	_	_
16	approvals	_	NNS	_	_	14	OBJ	_	_
17	to	_	TO	_	_	16	NMOD	_	_
18	enter	_	VB	_	_	17	IM	_	_
19	that	_	DT	_	_	20	NMOD	_	_
20	market	_	NN	_	_	18	OBJ	_	_
21	in	_	IN	_	_	14	LOC	_	_
22	the	_	DT	_	_	23	NMOD	_	_
23	U.S.	_	NNP	_	_	21	PMOD	_	_
24	and	_	CC	_	_	23	COORD	_	_
25	Japan	_	NNP	_	_	24	CONJ	_	_
26	.	_	.	_	_	2	P	_	_

1	Mr.	_	NNP	_	_	2	TITLE	_	_
2	Bergsma	_	NNP	_	_	3	SBJ	_	_
3	said	_	VBD	_	_	0	ROOT	_	_
4	Akzo	_	NNP	_	_	5	SBJ	_	_
5	hopes	_	VBZ	_	_	3	OBJ	_	_
6	to	_	TO	_	_	5	OPRD	_	_
7	have	_	VB	_	_	6	IM	_	_
8	approval	_	NN	_	_	7	OBJ	_	_
9	to	_	TO	_	_	8	NMOD	_	_
10	sell	_	VB	_	_	9	IM	_	_
11	its	_	PRP$	_	_	13	NMOD	_	_
12	Marvelon	_	NNP	_	_	13	NMOD	_	_
13	pill	_	NN	_	_	10	OBJ	_	_
14	in	_	IN	_	_	10	LOC	_	_
15	the	_	DT	_	_	16	NMOD	_	_
16	U.S.	_	NNP	_	_	14	PMOD	_	_
17	in	_	IN	_	_	7	TMP	_	_
18	1992	_	CD	_	_	17	PMOD	_	_
19	.	_	.	_	_	3	P	_	_

1	Akzo	_	NNP	_	_	3	SBJ	_	_
2	also	_	RB	_	_	3	ADV	_	_
3	has	_	VBZ	_	_	0	ROOT	_	_
4	small	_	JJ	_	_	5	NMOD	_	_
5	operations	_	NNS	_	_	3	OBJ	_	_
6	in	_	IN	_	_	5	LOC	_	_
7	diagnostic	_	JJ	_	_	8	NMOD	_	_
8	tests	_	NNS	_	_	6	PMOD	_	_
9	,	_	,	_	_	8	P	_	_
10	generic	_	JJ	_	_	11	NMOD	_	_
11	drugs	_	NNS	_	_	8	COORD	_	_
12	and	_	CC	_	_	11	COORD	_	_
13	veterinary	_	JJ	_	_	14	NMOD	_	_
14	products	_	NNS	_	_	12	CONJ	_	_
15	.	_	.	_	_	3	P	_	_

1	Veterinary	_	JJ	_	_	2	NMOD	_	_
2	products	_	NNS	_	_	3	SBJ	_	_
3	are	_	VBP	_	_	11	OBJ	_	_
4	showing	_	VBG	_	_	3	VC	_	_
5	especially	_	RB	_	_	6	AMOD	_	_
6	strong	_	JJ	_	_	7	NMOD	_	_
7	growth	_	NN	_	_	4	OBJ	_	_
8	,	_	,	_	_	11	P	_	_
9	Mr.	_	NNP	_	_	10	TITLE	_	_
10	Bergsma	_	NNP	_	_	11	SBJ	_	_
11	said	_	VBD	_	_	0	ROOT	_	_
12	.	_	.	_	_	11	P	_	_

1	Among	_	IN	_	_	5	LOC-PRD	_	_
2	the	_	DT	_	_	4	NMOD	_	_
3	leading	_	VBG	_	_	4	NMOD	_	_
4	products	_	NNS	_	_	1	PMOD	_	_
5	is	_	VBZ	_	_	0	ROOT	_	_
6	a	_	DT	_	_	8	NMOD	_	_
7	flu	_	NN	_	_	8	NMOD	_	_
8	shot	_	NN	_	_	5	SBJ	_	_
9	for	_	IN	_	_	8	NMOD	_	_
10	horses	_	NNS	_	_	9	PMOD	_	_
11	.	_	.	_	_	5	P	_	_

